Skip to main content
. Author manuscript; available in PMC: 2014 Apr 15.
Published in final edited form as: J Immunol. 2013 Mar 11;190(8):4324–4336. doi: 10.4049/jimmunol.1202045

FIGURE 8.

FIGURE 8

VEGF, IL-23, and IL-6 are significantly increased in non-lesional skin following BzATP treatments. Non-lesional and lesional explants were injected with BzATP or PBS (control). 24 h (VEGF and IL-6) and 72 h (IL-23) following treatment VEGF, IL-6, and IL-23 transcript expression levels were determined by the 2−ΔΔCt method. Bars represent the mean ± SD of triplicates. Asterisk indicates a significant difference compared to non-lesional explants, unless otherwise indicated, p < 0.05. Representative of three independent experiments.